Transvenous electrical cardioversion of equine atrial fibrillation: Patient factors and clinical results in 72 treatment episodes

Journal of Veterinary Internal Medicine

Volumn 22, Issue 3, 2008, Pages 609-615

  McGurrin, M Kimberly J ^a   Physick Sheard, P W ^a   Kenney, D G ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cardiac disease; Electrophysiology; Heart; Horse; Performance

Indexed keywords

ANIMALIA; CONGIOPODIDAE; EQUIDAE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HORSE; HORSE DISEASE; MALE; METHODOLOGY; SEX DIFFERENCE; SWAN GANZ CATHETER;

ANIMALS; ATRIAL FIBRILLATION; CATHETERIZATION, SWAN-GANZ; ELECTRIC COUNTERSHOCK; FEMALE; HEART CATHETERIZATION; HORSE DISEASES; HORSES; MALE; SEX FACTORS;

EID: 52449112884     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0081.x     Document Type: Article

References (34)

1. Morris DD, Fregin GF. Atrial fibrillation in horses: Factors associated with response to quinidine sulfate in 77 clinical cases. Cornell Vet 1982;72:339-349.
2. Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: New perspectives. J Vet Intern Med 1995;9:57-67.
3. Physick-Sheard PW. Atrial fibrillation. In: Colahan PT, Mayhew IG, Merritt AM, Moore JN, eds. Equine Medicine and Surgery, 5th ed.. St Louis, MO: Mosby; 1999:354-358.
4. Reef VB, Levitan CW, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. J Vet Intern Med 1988;2:1-6.
5. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-1420.
6. McGurrin MKJ, Physick-Sheard PW, Kenney DG, et al. Transvenous electrical cardioversion in equine atrial fibrillation: Technique and successful treatment of 3 horses. J Vet Intern Med 2003;17:715-718.
7. McGurrin MKJ, Physick-Sheard PW, Kenney DG, et al. Transvenous electrical cardioversion of equine atrial fibrillation: Technical considerations. J Vet Intern Med 2005;19:695-702.
8. McGurrin MKJ, Physick-Sheard PW, Kenney DG. How to perform transvenous electrical cardioversion in horses with atrial fibrillation. J Vet Cardiol 2005;7:109-119.
9. Carlsten JC. Two-dimensional, real-time echocardiography in the horse. Vet Radiol 1987;28:76-87.
10. Young LE, Scott GR. Measurement of cardiac function by transthoracic echocardiography: Day to day variability and repeatability in normal Thoroughbred horses. Equine Vet J 1998;30:117-122.
11. Kriz NG, Hodgson DR, Rose RJ. Changes in cardiac dimensions and indices of cardiac function during deconditioning in horses. Am J Vet Res 2000;61:1553-1560.
12. Alt E, Schmitt C, Ammer R, et al. Effect of electrode position on outcome of low-energy intracardiac cardioversion of atrial fibrillation. Am J Cardiol 1997;79:621-625.
13. Alt E, Ammer R, Schmitt C, et al. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 1997;18:1796-1804.
14. Saksena S, Prakash A, Mangeon L, et al. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995;76:913-921.
15. Bellei MHM, Physick-Sheard P, Kerr KL, et al. Anesthesia for transvenous electrical cardioversion in horses: A retrospective study. J Am Vet Med Assoc 2007;231:122-130.
16. Neter J, Wasserman W, Kutner MH. Applied Linear Regression Models, 2nd ed. Homewood, IL: Richard D. Irwin Inc; 1989.
17. van Loon G, De Clerc D, Tavernier R, et al. Transient complete atrioventricular block following transvenous electrical cardioversion of atrial fibrillation in a horse. Vet J 2005;170:124-127.
18. Vikenes K, Omvik P, Farstad M, et al. Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am Heart J 2000;140:690-696.
19. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001;22:1852-1923.
20. Phillips W, Giguere S, Franklin RP, et al. Cardiac troponin I in pastured and race-training Thoroughbred horses. J Vet Intern Med 2003;17:597-599.
21. Schwarzwald CC, Hardy J, Buccellato M. High cardiac troponin I serum concentration in a horse with multiform ventricular tachycardia and myocardial necrosis. J Vet Intern Med 2003;17:364-368.
22. Frye MA, Selders CG, Mama KR, et al. Use of biphasic electrical cardioversion for treatment of idiopathic atrial fibrillation in two horses. J Am Vet Med Assoc 2002;220:1039-1045, 1007.
23. Slack JA, McGuirk SM, Erb HN, et al. Biochemical markers of cardiac injury in normal, surviving septic, or nonsurviving septic neonatal foals. J Vet Intern Med 2005;19:577-580.
24. Allan JJ, Feld RD, Russell AA, et al. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997;30:1052-1056.
25. Rao AC, Naeem N, John C, et al. Direct current cardioversion does not cause cardiac damage: Evidence from cardiac troponin T estimation. Heart 1998;80:229-230.
26. O'Brien PJ, Dameron GW, Beck ML, Brandt M. Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin-T immunoassays. Res Vet Sci 1998;65:135-137.
27. O'Brien PJ, Landt Y, Ladenson JH. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem 1997;43:2333-2338.
28. Rishniw M, Simpson KW. Cloning and sequencing of equine cardiac troponin I and confirmation of its usefulness as a target analyte for commercial troponin I analyzers. J Vet Diagn Invest 2005;17:582-584.
29. Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ 2005;173:1191-1202.
30. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: The present and the future. J Am Coll Cardiol 2006;48:1-11.
31. Adams JE III Clinical application of markers of cardiac injury: Basic concepts and new considerations. Clin Chim Acta 1999;284:127-134.
32. Bonnefoy E, Chevalier P, Kirkorian G, et al. Cardiac troponin I does not increase after cardioversion. Chest 1997;111:15-18.
33. Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999;42:298-308.
34. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.